| Israel | Turkey | Austria | |
| Oncological Check-up for Man | from $500 | from $500 | from $500 |
No hidden fees – just official clinic prices. Pay at the clinic for Oncological Check-up for Man upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Oncological Check-up for Man and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Oncological Check-up for Man journey.
Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).
Specialty:
Education and specialization:
Membership:
The doctor is a leading gastroenterologist with over 30 years of experience in treating gastrointestinal tract tumors. Specializing in the prevention, early diagnostics, and treatment of GI cancers, the doctor heads the Cancer Prevention Center at Sourasky Medical Center.
With a degree in general medicine from the Hebrew University and a specialty in gastroenterology from Tel Aviv University, the doctor has conducted research at NewYork-Presbyterian Center. The doctor has published over 300 papers and is a member of several prestigious organizations, including the American Association for Cancer Research and the European Society of Digestive Oncology.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.